C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/575 (2006.01) A61K 38/22 (2006.01) A61P 3/10 (2006.01) C07K 14/605 (2006.01) C07K 14/765 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2501421
Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
Bridon Dominique P.
Ezrin Alan M.
Holmes Darren L.
L'archeveque Benoit
Leblanc Anouk
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Conjuchem Biotechnologies Inc.
Conjuchem Inc.
LandOfFree
Long lasting exendin-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long lasting exendin-4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long lasting exendin-4 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1798598